Cargando...
2041. Impact of T2 Candida Panel on Species Specific Anti-fungal De-escalation
BACKGROUND: Empiric antifungal treatment is recommended in patients with suspected candidemia given the 20–40% associated mortality. T2Candida Panel (T2) is approved for the rapid detection directly on a blood sample of candidemia caused by C. albicans/C. tropicalis (CA/CT), C. parapsilosis (CP), C....
Guardado en:
| Publicado en: | Open Forum Infect Dis |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6252867/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1697 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|